Complete 3 day programme
Wednesday programme Friday programme
Day 1
A Multidisciplinary Thyroid Eye Disease session with the aim of enabling equitable patient access for TED services on a regional basis
The final format of the session will be democratically determined
by a survey of the membership
Please fill in the 5 minute survey here
Chaired by:
09.40 Miss Faye Mellington (Birmingham),
09.44 Miss Rebecca Ford (Bristol),
09.48 Miss Anjana Haridas (Cardiff),
09.52 Mr Steven White (Belfast),
09.56 Paul Cauchi (Scotland)
10.05 am
Unravelling the code of Graves’ Orbitopathy – The importance of serial TSH-Receptor Antibody levels in predicting prognosis and the impact of smoking, Radioiodine and Thyroidectomy 101
Vignesh Paulpandian – (abstract)
10.10 am
Measurement of changes in orbital compliance following orbital decompression surgery: a new quantitative technique 102
Richard Hart – (abstract)
10.15 am
Phenotypes in Thyroid Eye Disease 103
Jimmy Uddin – (abstract)
10.20 am
An Audit of the Use of Radiotherapy in Thyroid Eye Disease (TED) at a Tertiary Referral Centre 104
James Young – (abstract)
10.25 am
A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy 105
Yun Wong – (abstract)
10.30 am
Proposing audit standards for joint thyroid eye disease clinics: a 5 year audit of the patient pathway 106
Sonali Nagendran – (abstract)
10.35 am
Combined IntraVenous methylprednisolone with orbital radiotherapy for the treatment of thyroid eye disease. The Sheffield experience. 107
Konstantinos Kopsidas – (abstract)
10.40 am
Application of 3D imaging system for orbital volume changes after orbital decompression on Thyroid Eye Disease 108
Fabiola Murta – (abstract)
Chaired by:
Chaired by:
14.05 pm
UV imaging reveals areas on the face that are prone to skin cancer are disproportionately missed during sunscreen application. 109
Kareem Hassanin – (abstract)
14.10 pm
Evaluating eyelid profile after ptosis repair 110
Christopher Schulz – (abstract)
14.15 pm
Primary mucinous carcinoma of the eyelid 111
John Bladen – (abstract)
14.20 pm
5% Imiquimod for Superficial, Nodular and Mixed Type Basal Cell Carcinoma: 3- Year Results 112
Dimitra Gousia – (abstract)
14.25 pm
The national incidence of squamous cell carcinomas in England over a fifteen year period 113
James Wawrzynski – (abstract)
14.30 pm
Corneal Neurotization: Restoration of Corneal Sensation with Regional Nerve Grafts 114
Raman Malhotra – (abstract)
14.35 pm
Considerations of upper blepharoplasty with respect to skin excision and skin crease position: a prospective study of 150 cases. 115
Paul Rosser – (abstract)
14.40 pm
Peri-Ocular and facial lipofilling 116
Michel Tazartes – (abstract)
Chaired by:
Chaired by:
Chaired by:
A Multidisciplinary Thyroid Eye Disease session with the aim of enabling equitable patient access for TED services on a regional basis
The final format of the session will be democratically determined
by a survey of the membership
Please fill in the 5 minute survey here
Chaired by:
09.40 Miss Faye Mellington (Birmingham),
09.44 Miss Rebecca Ford (Bristol),
09.48 Miss Anjana Haridas (Cardiff),
09.52 Mr Steven White (Belfast),
09.56 Paul Cauchi (Scotland)
10.05 am
Unravelling the code of Graves’ Orbitopathy – The importance of serial TSH-Receptor Antibody levels in predicting prognosis and the impact of smoking, Radioiodine and Thyroidectomy 101
Vignesh Paulpandian – (abstract)
10.10 am
Measurement of changes in orbital compliance following orbital decompression surgery: a new quantitative technique 102
Richard Hart – (abstract)
10.15 am
Phenotypes in Thyroid Eye Disease 103
Jimmy Uddin – (abstract)
10.20 am
An Audit of the Use of Radiotherapy in Thyroid Eye Disease (TED) at a Tertiary Referral Centre 104
James Young – (abstract)
10.25 am
A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy 105
Yun Wong – (abstract)
10.30 am
Proposing audit standards for joint thyroid eye disease clinics: a 5 year audit of the patient pathway 106
Sonali Nagendran – (abstract)
10.35 am
Combined IntraVenous methylprednisolone with orbital radiotherapy for the treatment of thyroid eye disease. The Sheffield experience. 107
Konstantinos Kopsidas – (abstract)
10.40 am
Application of 3D imaging system for orbital volume changes after orbital decompression on Thyroid Eye Disease 108
Fabiola Murta – (abstract)
Chaired by:
Chaired by:
14.05 pm
UV imaging reveals areas on the face that are prone to skin cancer are disproportionately missed during sunscreen application. 109
Kareem Hassanin – (abstract)
14.10 pm
Evaluating eyelid profile after ptosis repair 110
Christopher Schulz – (abstract)
14.15 pm
Primary mucinous carcinoma of the eyelid 111
John Bladen – (abstract)
14.20 pm
5% Imiquimod for Superficial, Nodular and Mixed Type Basal Cell Carcinoma: 3- Year Results 112
Dimitra Gousia – (abstract)
14.25 pm
The national incidence of squamous cell carcinomas in England over a fifteen year period 113
James Wawrzynski – (abstract)
14.30 pm
Corneal Neurotization: Restoration of Corneal Sensation with Regional Nerve Grafts 114
Raman Malhotra – (abstract)
14.35 pm
Considerations of upper blepharoplasty with respect to skin excision and skin crease position: a prospective study of 150 cases. 115
Paul Rosser – (abstract)
14.40 pm
Peri-Ocular and facial lipofilling 116
Michel Tazartes – (abstract)
Chaired by:
Chaired by:
Chaired by: